Demand side cost-sharing and prescription drugs utilization: evidence from a quasi-natural experiment

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985998%3A_____%2F13%3A00440562" target="_blank" >RIV/67985998:_____/13:00440562 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Demand side cost-sharing and prescription drugs utilization: evidence from a quasi-natural experiment

Popis výsledku v původním jazyce

In this paper we investigate the effects of introduction of lump sum copayments on the utilization of prescription drugs by elderly patients. We make use of an unique dataset and analyze the policy change that implemented patient cost-sharing in the Czech Republic starting in 2008. After the introduction of copayments the number of prescriptions filled decreased by 29%. At the same time, however, total expenditures on prescription drugs dropped only in the first quarter of the post-introduction period and then returned to previous levels. This was partially due to behavioral responses of patients and physicians: strategic shift of prescription purchases to the time right before the introduction of reform, prescription of more packages on one prescription and an upward shift in the price composition of prescribed drugs. Moreover, patients in general decided to forego those types of drugs that did not cause immediate worsening of health status.

Název v anglickém jazyce

Demand side cost-sharing and prescription drugs utilization: evidence from a quasi-natural experiment

Popis výsledku anglicky

In this paper we investigate the effects of introduction of lump sum copayments on the utilization of prescription drugs by elderly patients. We make use of an unique dataset and analyze the policy change that implemented patient cost-sharing in the Czech Republic starting in 2008. After the introduction of copayments the number of prescriptions filled decreased by 29%. At the same time, however, total expenditures on prescription drugs dropped only in the first quarter of the post-introduction period and then returned to previous levels. This was partially due to behavioral responses of patients and physicians: strategic shift of prescription purchases to the time right before the introduction of reform, prescription of more packages on one prescription and an upward shift in the price composition of prescribed drugs. Moreover, patients in general decided to forego those types of drugs that did not cause immediate worsening of health status.

Druh

D - Stať ve sborníku

CEP obor

AH - Ekonomie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2013

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název statě ve sborníku

Impacts of Ageing on Public Finances and Labour Markets in EU Regions: Theoretical Models and Empirical Analyses

ISBN

978-80-7144-214-1

ISSN

—

e-ISSN

—

Počet stran výsledku

16

Strana od-do

170-185

Název nakladatele

The Institute of Economic Research of the Slovak Academy of Sciences

Místo vydání

Bratislava

Místo konání akce

Smolenice

Datum konání akce

28. 10. 2013

Typ akce podle státní příslušnosti

EUR - Evropská akce

Kód UT WoS článku

000335871100014